Accessibility Menu
Arrow-Thin-Down
S&P 500
6,716.09
+0.2%
+16.71
Arrow-Thin-Down
DJI
46,993.26
+0.1%
+46.85
Arrow-Thin-Down
NASDAQ
22,479.53
+0.5%
+105.35
Arrow-Thin-Down
Bitcoin
$74,467.00
+0.1%
+$84.74
Arrow-Thin-Down
AMZN
$215.20
+1.6%
+$3.46
Arrow-Thin-Down
GOOG
$309.41
+1.6%
+$4.99
Arrow-Thin-Down
META
$622.43
-0.8%
-$5.02
Arrow-Thin-Down
MSFT
$399.44
-0.1%
-$0.51
Arrow-Thin-Down
NVDA
$181.86
-0.7%
-$1.36
Arrow-Thin-Down
TSLA
$398.63
+0.8%
+$3.07
Most Active StocksDaily Stock GainersDaily Stock Losers

Hims & Hers Is Changing the Game

GLP-1s could be the product that pushes Hims & Hers over the edge to mainstream adoption.

By Travis Hoium – May 22, 2024 at 4:36AM EST

Hims & Hers (HIMS +0.66%) has been a great growth stock since coming public, but it's now starting to turn a profit. In this video, Travis Hoium highlights the company's financials and why the launch of GLP-1 medications could be a game-changer.

*Stock prices used were end-of-day prices of May 20, 2024. The video was published on May 21, 2024.

Read Next

About the Author

Travis Hoium
Travis Hoium is a contributing Motley Fool stock market analyst covering solar energy, technology, and growth stocks. Before The Motley Fool, Travis was a mechanical engineer at 3M and founded a virtual reality company. He holds a bachelor’s degree in mechanical engineering and a master’s degree in business administration from the University of Minnesota.
TMFFlushDraw
X@travishoium

Travis Hoium has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Travis Hoium is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link, they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.

Stocks Mentioned

Hims & Hers Health Stock Quote
Hims & Hers Health
NYSE: HIMS
$25.05
(+0.66%)+$0.17

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services